Chronic kidney disease of nontraditional causes, mortality rates and hospital discharges
DOI:
https://doi.org/10.51481/amc.v64i1.1145Keywords:
Chronic kidney failure, epidemiology, mortality registries, patient discharge, Costa RicaAbstract
Aim: To describe the trends of the primary diagnosis of death, the diagnosis of hospital discharge, as well as years of potential life lost by patients with chronic kidney disease compatible with chronic kidney disease of non-traditional causes according to data registered in public access databases in the country between 2014 and 2019.
Methods: a longitudinal descriptive study of the information on deaths and hospital discharges registered in public access databases on the primary diagnosis of chronic kidney disease compatible with chronic kidney disease of non-traditional causes was carried out. With the results obtained, absolute and relative percentages and frequencies were calculated for mortality and hospital discharges. The general, specific, and adjusted mortality rates were calculated by the direct method. In addition, years of potential life lost in the country were estimated by province and sex.
Results: in Costa Rica, between 2014 and 2019, 2,548 deaths and 1,893 hospital discharges related to chronic kidney disease of non-traditional causes were recorded. Adjusted mortality rates were found to be elevated for the provinces of Guanacaste and Limón compared to national rates and relative to other provinces. In the province of Guanacaste, in addition, the trend of discharges was high. Additionally, it was detected that years of potential life lost showed a progressive and constant increase in the country, predominantly in the male sex and in the province of Guanacaste. Thirteen deaths of persons under twenty years of age were reported.
Conclusion: updating the data on mortality trends has made it possible to identify that the provinces of Guanacaste and Limón have adjusted rates higher than the national average, as well as lower average ages of death according to the rest of the provinces. Deaths and hospital discharges in people under 20 years of age suggest early kidney damage unrelated to occupational disease. Mortality and lost years of potential life lost provide information on the burden of disease in the country's population. It should be added that the specific coding to monitor the pathology was scarcely recorded in the study period.
Downloads
References
Chapman E, Haby MM, Illanes E, Sanchez-Viamonte J, Elias V, Reveiz L. Risk factors for chronic kidney disease of non-traditional causes: a systematic review. Pan Am. J. Public. 2019;43:e35-e.
Pearce N, Caplin B. Let's take the heat out of the CKDu debate: more evidence is needed. Occup Environ Med. 2019;76:357-359.
Rivera-Chavarría A, Méndez-Chacón E. Mortalidad y egresos hospitalarios por enfermedad renal crónica compatibles con enfermedad crónica de causas no tradicionales, Costa Rica. Acta méd. costarric. 2016;58:1-14.
Cerdas M. Chronic kidney disease in Costa Rica. Kidney Int Suppl. 2005:S31-3.
Wesseling C, van Wendel de Joode B, Crowe J, Rittner R, Sanati NA, Hogstedt C, et al. Mesoamerican nephropathy: geographical distribution and time trends of chronic kidney disease mortality between 1970 and 2012 in Costa Rica. Occup Environ Méd. 2015;72:714-721.
Rodríguez P, Robles M, Dierssen T, Escudero M, Llorca J. Influencia de la población estándar sobre las tasas de mortalidad ajustadas por edad: el ejemplo del cáncer de cérvix en España. Rev. Esp. Salud Publica. 2004; 78: 709-712.
Martinez R, Soliz P, Caixeta R, Ordunez P. Reflection on modern methods: years of life lost due to premature mortality-a versatile and comprehensive measure for monitoring non-communicable disease mortality. Int J Epidemiol. 2019;48:1367-1376.
Vlasschaert ME, Bejaimal SA, Hackam DG, Quinn R, Cuerden MS, Oliver MJ, et al. Validity of administrative database coding for kidney disease: a systematic review. Am J Kidney Dis. 2011;57:29-43.
Fleet JL, Dixon SN, Shariff SZ, Quinn RR, Nash DM, Harel Z, et al. Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol. 2013;14:81.
Jalal K, Anand EJ, Venuto R, Eberle J, Arora P. Can billing codes accurately identify rapidly progressing stage 3 and stage 4 chronic kidney disease patients: a diagnostic test study. BMC Nephrol. 2019;20:260.
Bello AK, Ronksley PE, Tangri N, Singer A, Grill A, Nitsch D, et al. A national surveillance project on chronic kidney disease management in Canadian primary care: a study protocol. BMJ Open. 2017;7:e016267.
Powe NR, Plantinga L, Saran R. Public health surveillance of CKD: principles, steps, and challenges. Am. J. Kidney Dis. 2009;53:S37-S45.
Ramalle-Gomara E, Ruiz E, Serrano M, Bártulos M, González M, Matute B. Hospital discharges and mortality registries: 2 complementary databases for the epidemiological surveillance of stroke. J Stroke Cerebrovasc Dis. 2013;22:e441-5.
Wang J, Bao B, Shen P, Kong G, Yang Y, Sun X, et al. Using electronic health record data to establish a chronic kidney disease surveillance system in China: protocol for the China Kidney Disease Network (CK-NET)-Yinzhou Study. BMJ Open. 2019;9:e030102.
Wesseling C, Glaser J, Rodríguez-Guzmán J, Weiss I, Lucas R, Peraza S, et al. Chronic kidney disease of non-traditional origin in Mesoamerica: a disease primarily driven by occupational heat stress. Pan Am. J. Public Health. 2020;44:e15-e.
Harhay MN, Harhay MO, Coto-Yglesias F, Rosero Bixby L. Altitude and regional gradients in chronic kidney disease prevalence in Costa Rica: Data from the Costa Rican Longevity and Healthy Aging Study. Trop. Méd. Int. Health. 2016; 21:41-51.
Hansson E, Mansourian A, Farnaghi M, Petzold M, Jakobsson K. An ecological study of chronic kidney disease in five Mesoamerican countries: associations with crop and heat. BMC Public Health. 2021;21:840.
O'Donnell JK, Tobey M, Weiner DE, Stevens LA, Johnson S, Stringham P, et al. Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol. Dial. Transplant. 2011;26:2798-2805.
Torres C, Aragón A, González M, López I, Jakobsson K, Elinder CG, et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis. 2010;55:485-496.
Morales R. Metodología de análisis del riesgo por contaminación de agroquímicos: cuenca del Río San Blas, Costa Rica. Rev. costarric. salud pública. 2013;22:34-44.
Mendoza EC, González C, Martínez- MC, Avelar F, Valdivia A, Aldana ML, et al. Estudio de exposición a malatión y cipermetrina y su relación con el riesgo de daño renal en habitantes del municipio de Calvillo Aguascalientes, México. Rev Mex Cienc Farm. 2015;46:62-72.
Raj J, Mohineesh, Ray R, Dogra TD, Raina A. Acute oral toxicity and histopathological study of combination of endosulfan and cypermethrin in wistar rats. Toxicol. Int. 2013;20:61-67.
Afolabi OK, Aderibigbe FA, Folarin DT, Arinola A, Wusu AD. Oxidative stress and inflammation following sub-lethal oral exposure of cypermethrin in rats: mitigating potential of epicatechin. Heliyon. 2019;5:e02274.
Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman DH. Resolving the enigma of the mesoamerican nephropathy: a research workshop summary. Am J Kidney Dis. 2014;63:396-404.
Butler-Dawson J, Krisher L, Yoder H, Dally M, Sorensen C, Johnson RJ, et al. Evaluation of heat stress and cumulative incidence of acute kidney injury in sugarcane workers in Guatemala. Int Arch Occup Environ Health. 2019;92(7):977-990.
Lunyera J, Mohottige D, Isenburg MV, Jeuland M, Patel UD, Stanifer JW. CKD of Uncertain Etiology: A Systematic Review. Clin. J. Am. Soc. Nephrol. 2016;11:379.
Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709-733.
Brustugun OT, Møller B, Helland A. Years of life lost as a measure of cancer burden on a national level. British journal of cancer. 2014;111:1014-1020.
Ricardo AC, Yang W, Sha D, Appel LJ, Chen J, Krousel-Wood M, et al. Sex-Related Disparities in CKD Progression. J Am Soc Nephrol. 2019;30:137-146.
Perez-Gomez MV, Martin-Cleary C, Fernandez-Fernandez B, Ortiz A. Meso-American nephropathy: what we have learned about the potential genetic influence on chronic kidney disease development*. Clin. Kidney J. 2018;11:491-495.
Agampodi SB, Amarasinghe GS, Naotunna PGCR, Jayasumana CS, Siribaddana SH. Early renal damage among children living in the region of highest burden of chronic kidney disease of unknown etiology (CKDu) in Sri Lanka. BMC Nephrol. 2018;19:115-.
Ramírez-Rubio O, Amador JJ, Kaufman JS, Weiner DE, Parikh CR, Khan U, et al. Urine biomarkers of kidney injury among adolescents in Nicaragua, a region affected by an epidemic of chronic kidney disease of unknown aetiology. Nephrol Dial Transplant. 2016;31:424-432.
Orantes C, Herrera R, Almaguer M, Brizuela E, Alvarado N, Fuentes E, et al. Chronic kidney disease in children and adolescents in Salvadoran Farming Communities: NefroSalva Pediatric Study (2009-2011). MEDICC Rev. 2016;18:15-21.
Cerón A, Ramay BM, Méndez LP, Lou- R. Factors associated with chronic kidney disease of non-traditional causes among children in Guatemala. Pan Am. J. Public Health. 2021;45:e24-e.
Published
Issue
Section
License
Copyright (c) 2022 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
